The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
The natural ability of some children's immune systems to hold off attacking HIV, thus stopping diseases progression, may provide clues for future treatment.
Nearly US$ 13 billion has been pledged to the Global Fund to Fight AIDS, Tuberculosis and Malaria, to accelerate the response to end these diseases over the next three years.
The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.
The Gates Foundation awards grant to expand access to pre-exposure prophylaxis (PrEP) for key populations in Kenya.
An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer infections, the 21st International AIDS Conference in Durban, South Africa heard last month.